|
|
|
|
|||||
|
|
|
American Healthcare REIT, Inc. (NYSE:AHR) is included among the 14 Best Up and Coming Dividend Stocks to Buy.
On November 20, Morgan Stanley increased its price target on American Healthcare REIT, Inc. (NYSE:AHR) to $55 from $52, keeping an Overweight rating, according to a report by The Fly. After reviewing the company’s third-quarter numbers and the broader supply-and-demand backdrop in senior housing, the firm said it has growing confidence in both Welltower and American Healthcare’s ability to capture additional margin upside.
For Q3 2025, American Healthcare REIT, Inc. (NYSE:AHR) reported GAAP net income attributable to controlling interest of $55.9 million, or $0.33 per diluted share. Same-store NOI for the portfolio rose 16.4%, reflecting strong operating momentum. The company also stayed busy on the acquisition front, closing roughly $210.8 million worth of deals during the quarter and more than $575 million in new acquisitions year-to-date.
Management also highlighted a new partnership with WellQuest Living, along with a development pipeline that is expected to cost around $177 million. The company also raised its full-year 2025 normalized FFO guidance to a range of $1.69 to $1.72 per diluted share, up from the prior outlook of $1.64 to $1.68, pointing to better-than-expected organic growth and ongoing improvement in occupancy.
American Healthcare REIT, Inc. (NYSE:AHR) is a publicly traded REIT investing in and operating a broad mix of healthcare real estate, with a focus on senior housing, skilled nursing facilities, and outpatient medical properties across the US, the U.K., and the Isle of Man.
While we acknowledge the potential of AHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Best Boring Dividend Stocks to Buy and 15 Best Stocks to Buy for Medium Term.
Disclosure: None.
| Dec-01 | |
| Dec-01 | |
| Nov-20 | |
| Nov-20 | |
| Nov-14 | |
| Nov-08 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite